Literature DB >> 25213403

Obesity measures and risk of venous thromboembolism and myocardial infarction.

Lars D Horvei1, Sigrid K Brækkan, Ellisiv B Mathiesen, Inger Njølstad, Tom Wilsgaard, John-Bjarne Hansen.   

Abstract

Obesity is a risk factor for arterial and venous thromboembolism. However, it is not known whether obesity mediates risk through shared mechanisms. In a population-based cohort, we aimed to compare the impact of obesity measures on risk of venous thromboembolism (VTE) and myocardial infarction (MI), and explore how obesity-related atherosclerotic risk factors influenced these relationships. Measures of body composition including body mass index , waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR) and waist-to-height ratio (WHtR) were registered in 6,708 subjects aged 25-84 years, who participated in the Tromsø Study (1994-1995). Incident VTE- and MI-events were registered until January 1, 2011. There were 288 VTEs and 925 MIs during a median of 15.7 years of follow-up. All obesity measures were related to risk of VTE. In linear models, WC showed the highest risk estimates in both genders. In categorized models (highest versus lowest quintile), WC showed highest risk in men (HR 3.59; 95 % CI 1.82-7.06) and HC in women (HR 2.27; 95 % CI 1.54-4.92). Contrary, WHR and WHtR yielded the highest risk estimates for MI. The HR of MI (highest vs. lowest quintile) for WHR was 2.11 (95 % CI 1.59-2.81) in men and 1.62 (95 % CI 1.13-2.31) in women. The risk estimates for MI were substantially attenuated after adjustment for atherosclerotic risk factors, whereas the estimates for VTE remained unchanged. Our findings suggest that the impact of body fat distribution, and the causal pathway, differs for the association between obesity and arterial and venous thrombosis.

Entities:  

Mesh:

Year:  2014        PMID: 25213403     DOI: 10.1007/s10654-014-9950-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  55 in total

1.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

2.  Larger hip circumference independently predicts health and longevity in a Swedish female cohort.

Authors:  L Lissner; C Björkelund; B L Heitmann; J C Seidell; C Bengtsson
Journal:  Obes Res       Date:  2001-10

3.  Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.

Authors:  P W Kamphuisen; J C Eikenboom; H L Vos; R Pablo; A Sturk; R M Bertina; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

Review 4.  Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights.

Authors:  Sigrid K Braekkan; Bob Siegerink; Willem M Lijfering; John-Bjarne Hansen; Suzanne C Cannegieter; Frits R Rosendaal
Journal:  Semin Thromb Hemost       Date:  2013-04-27       Impact factor: 4.180

5.  Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study.

Authors:  J C Seidell; L Pérusse; J P Després; C Bouchard
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

6.  Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis.

Authors:  Keattiyoat Wattanakit; Pamela L Lutsey; Elizabeth J Bell; Heather Gornik; Mary Cushman; Susan R Heckbert; Wayne D Rosamond; Aaron R Folsom
Journal:  Thromb Haemost       Date:  2012-07-10       Impact factor: 5.249

7.  Age, socioeconomic status and obesity growth.

Authors:  Charles L Baum; Christopher J Ruhm
Journal:  J Health Econ       Date:  2009-02-05       Impact factor: 3.883

8.  Hip circumference and cardiovascular morbidity and mortality in men and women.

Authors:  Berit L Heitmann; Peder Frederiksen; Lauren Lissner
Journal:  Obes Res       Date:  2004-03

9.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

10.  Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.

Authors:  Caroline Lind; Linda E Flinterman; Kristin F Enga; Marianne T Severinsen; Søren R Kristensen; Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Suzanne C Cannegieter; Kim Overvad; John-Bjarne Hansen
Journal:  Circulation       Date:  2013-11-22       Impact factor: 29.690

View more
  27 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population.

Authors:  Nadia Arshad; Trond Isaksen; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Eur J Epidemiol       Date:  2017-03-17       Impact factor: 8.082

3.  Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery.

Authors:  Jérémie Thereaux; Fanny Mingant; Charles Roche; Hubert Galinat; Francis Couturaud; Karine Lacut
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

4.  Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis.

Authors:  Cary C Cotton; Donna Baird; Robert S Sandler; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

Review 5.  Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Jean C McSweeney; Anne G Rosenfeld; Willie M Abel; Lynne T Braun; Lora E Burke; Stacie L Daugherty; Gerald F Fletcher; Martha Gulati; Laxmi S Mehta; Christina Pettey; Jane F Reckelhoff
Journal:  Circulation       Date:  2016-02-29       Impact factor: 29.690

6.  Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Mary Cushman; Ellen S O'Meara; Susan R Heckbert; Neil A Zakai; Wayne Rosamond; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-06-15       Impact factor: 3.944

Review 7.  The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants.

Authors:  Morgana L Mongraw-Chaffin; Sanne A E Peters; Rachel R Huxley; Mark Woodward
Journal:  Lancet Diabetes Endocrinol       Date:  2015-05-07       Impact factor: 32.069

8.  Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Authors:  Aditya V Karhade; Luis Fandino; Saksham Gupta; David J Cote; Julian B Iorgulescu; Marike L Broekman; Linda S Aglio; Ian F Dunn; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

9.  Bariatric Surgery Outcomes in Patients on Preoperative Therapeutic Anticoagulation: an Analysis of the 2015 to 2017 MBSAQIP.

Authors:  Aryan Modasi; Jerry T Dang; Sadaf Afraz; Joshua Hefler; Noah Switzer; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

10.  Adiposity throughout the life course and risk of venous thromboembolism.

Authors:  Kaitlin A Hagan; Laura B Harrington; Jihye Kim; Sara Lindström; Carlos A Camargo; Francine Grodstein; Christopher Kabrhel
Journal:  Thromb Res       Date:  2018-10-26       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.